The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DIRECT2: A randomized phase III trial with a fasting mimicking diet program to improve chemotherapy in patients with hormone receptor positive, HER2-negative breast cancer—A Dutch Breast Cancer Research Group study (BOOG).
 
Nadia de Gruil
No Relationships to Disclose
 
Gerrit-Jan Liefers
No Relationships to Disclose
 
Sanne B. Schagen
No Relationships to Disclose
 
Elma Meershoek – Klein Kranenbarg
No Relationships to Disclose
 
Marielle E. Veen-Lievaart
No Relationships to Disclose
 
Chris Hinnen
No Relationships to Disclose
 
Hein Putter
No Relationships to Disclose
 
Joan B. Heijns
No Relationships to Disclose
 
Anniek Goosens
No Relationships to Disclose
 
Jolien Tol
No Relationships to Disclose
 
Arnold Baars
No Relationships to Disclose
 
Gerrit Jan Veldhuis
No Relationships to Disclose
 
Lonneke W. Kessels
No Relationships to Disclose
 
Agnes J. van de Wouw
Employment - Sanofi (I)
 
Annelie J.E. Vulink
No Relationships to Disclose
 
Frank A.J. Toonen
No Relationships to Disclose
 
Daan ten Bokkel Huinink
No Relationships to Disclose
 
Sjoerd H. van der Burg
Research Funding - Enara Bio (Inst); Frame Therapeutics (Inst); Mendus (Inst)
Patents, Royalties, Other Intellectual Property - patents concerning tumor antigens; vaccine development and adoptive cell transfer with TCRs (Inst)
 
Hanno Pijl
Honoraria - Fontaine Publishing Group; Lannoo Publishers
Speakers' Bureau - Health Investment
 
Judith R. Kroep
Consulting or Advisory Role - AstraZeneca (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MDS (Inst); Novartis (Inst); Vitroscan (Inst)
Research Funding - AstraZeneca (Inst); Novartis (Inst); Philips Research (Inst)